BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents

Oncogene

Volumn 20, Issue 43, 2001, Pages 6123-6131

  Mullan, Paul B ^a   Quinn, Jennifer E ^a   Gilmore, Paula M ^a   McWilliams, Stewart ^a   Andrews, Heather ^a   Gervin, Celine ^a   McCabe, Nuala ^a   McKenna, Sarah ^a   White, Pat ^a   Song, Young Han ^b   Maheswaran, Shyamala ^c   Liu, Edison ^d   Haber, Daniel A ^b   Johnston, Patrick G ^a   Harkin, D Paul ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antimicrotubule agents; BRCA1; Cell death; G2 M arrest; GADD45

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; CISPLATIN; DOXORUBICIN; GENE PRODUCT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PACLITAXEL; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BREAST CANCER; CELL CYCLE G2 PHASE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; DNA PROBE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS SPINDLE; NORTHERN BLOTTING; OVARY CANCER; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CISPLATIN; DNA DAMAGE; DNA, COMPLEMENTARY; DOXORUBICIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROTUBULES; MITOSIS; PACLITAXEL; PHENOTYPE; PROTEINS; TIME FACTORS; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0035959804     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204712     Document Type: Article

References (41)